Molecular imaging developer Sofie Biosciences has received a grant from the U.S. Department of Energy (DOE) to advance the development of a benchtop, PC-controlled, microscale, chip-based commercial device for the on-demand production of PET radiopharmaceutical probes.
The goal is to create technology to allow scientists and clinicians to control the development and use of PET probes.
More than 1,600 PET probes have been developed to help answer a variety of biological questions, but only FDG is routinely used, the company noted. This limitation exists because of the current radiopharmacy-based approach to PET probe production, which can have high infrastructure costs and requires specialized equipment and skilled personnel.
